Therapy News and Research

RSS

AACE applauds the American Medical Association for recognizing obesity as disease state

The American Association of Clinical Endocrinologists (AACE) applauds the American Medical Association (AMA) House of Delegates for its action today to approve a resolution recognizing obesity as a disease state requiring a range of interventions to advance obesity treatment and prevention. AACE, the sponsor of the resolution, was joined by specialty and state medical societies in advocating for recognition of obesity as a disease state, including The Endocrine Society, American College of Cardiology, American College of Surgeons, American Urological Association, and the Texas State Delegation among many others.

19 Jun 2013

Thrombolytic treatment after stroke associated with reduced in-hospital mortality

In a study that included nearly 60,000 patients with acute ischemic stroke, thrombolytic treatment (to help dissolve a blood clot) that was started more rapidly after symptom onset was associated with reduced in-hospital mortality and intracranial hemorrhage and higher rates of independent walking ability at discharge and discharge to home, according to a study in the June 19 issue of JAMA.

19 Jun 2013

Psychologists must be educated to treat sexual minority youth

President Obama officially declared June as Lesbian, Gay, Bisexual and Transgender (LGBT) Pride Month. However, despite advances in civil rights, sexual minority youth are still at greater risk for suicide than their heterosexual peers, according to the Suicide Prevention Resource Center.

19 Jun 2013

Ico Therapeutics completes Phase 2 iDEAL study for treatment of diabetic macular edema

iCo Therapeutics Inc. announced today that it has completed enrollment of its Phase 2 iDEAL study evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). The study has shown a good safety profile with no drug-related serious adverse events to date.

19 Jun 2013

Journal of Bone and Joint Surgery reveals important trends and changes in orthopaedic practice

Data from the recent release from The Journal of Bone and Joint Surgery, The Third Annual Role of the Orthopaedic Surgeon Study 2013, reveals important trends in the ways that orthopaedic practice is changing in the face of significant increases in hospital-owned practices, cost pressures, and regulations.

19 Jun 2013

State highlights: Texas pharmacists want Medicaid price transparency

Pennsylvania is joining about 20 other states in limiting coverage of abortions under health care insurance policies offered in a federally-run insurance marketplace starting next year under a sweeping federal law. The office of Gov. Tom Corbett, a Republican who opposes abortion rights, said he signed the bill Monday, without offering any comment (6/17).

19 Jun 2013

Report examines Medicare spending issues, geographic disparities and hospital payments

The report from the congressional advisory group MedPAC assesses a variety of issues, including penalties that Medicare has recently begun imposing on hospitals and how that affects facilities largely serving poor patients.

18 Jun 2013

Scientists discover new anti-tuberculosis compound that kills drug-resistant TB bacteria

An international team led by scientists at The Scripps Research Institute (TSRI), the Howard Hughes Medical Institute and Albert Einstein College of Medicine of Yeshiva University has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium in two different ways.

18 Jun 2013

Hormone treatment to halt puberty in transgender adolescents is safe and effective

Hormone treatment to halt puberty in adolescents with gender identity disorder does not cause lasting harm to their bones, a new study finds. The results were presented today at The Endocrine Society's 95th Annual Meeting in San Francisco.

18 Jun 2013

OncoSec Medical completes enrollment in ImmunoPulse trial for metastatic melanoma patients

OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced the completion of patient enrollment in a Phase II clinical trial of ImmunoPulse for metastatic melanoma patients.

18 Jun 2013

DTE from animal thyroid glands is a safe alternative to T4 therapy in hypothyroid patients

Desiccated thyroid extract (DTE), derived from crushed preparations of animal thyroid glands, is a safe and effective alternative to standard T4 therapy in hypothyroid patients, a new study finds. The results will be presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.

18 Jun 2013

Combination of obesity and low testosterone increases risk of diabetes and brain damage

Low testosterone worsens the harmful effects of obesity in the nervous system, a new study in mice finds. The results will be presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.

18 Jun 2013

Genomic instability in new molecular pathway may predict worse outcomes in breast cancer patients

A new molecular pathway involving the gene ZNF365 has been identified and abnormalities in that pathway may predict worse outcomes for patients with breast cancer, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research.

18 Jun 2013

Estrogen replacement therapy reduces anxiety symptoms in girls with anorexia nervosa

Estrogen replacement therapy is associated with a significant decrease in anxiety symptoms among girls with anorexia nervosa, a new clinical trial finds. The results will be presented today at The Endocrine Society's Annual Meeting in San Francisco.

18 Jun 2013

Study: Whole body vibration therapy raises bone strength among adolescents with cerebral palsy

A treatment known as whole body vibration therapy significantly increases bone strength among adolescents with cerebral palsy, a new clinical trial from New Zealand shows. The results were presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

18 Jun 2013

Women with polycystic ovary syndrome lose more weight when they take two drugs

Women with polycystic ovary syndrome, or PCOS, lost significantly more weight when they took two drugs that are traditionally used to treat diabetes, rather than either drug alone, a study from Slovenia demonstrates. The results will be presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco.

18 Jun 2013

State highlights: States urge using life insurance for long-term care

State lawmakers are encouraging elderly residents to use life insurance as a way to pay for long-term care -- and lower the Medicaid tab in the process. The strategy marks a tacit endorsement of so-called life settlements, a practice in which policyholders sell their policies at a discount in the secondary market and the buyer takes over premiums and consequently collects the death benefit (Greene, 6/16).

18 Jun 2013

Vercise DBS System shows improvement in motor scores for patients with Parkinson's disease

Patients with Parkinson's disease using the Boston Scientific Corporation Vercise DBS (deep brain stimulation) System showed a significant improvement in motor scores according to interim data from the VANTAGE DBS study.

18 Jun 2013

TWi Biotechnology completes patient enrollment in phase II trial of AC-201 for Gout Flare Prophylaxis

TWi Biotechnology, Inc. announced that it has completed the patient enrollment in a phase II trial of AC-201 for Gout Flare Prophylaxis during urate-lowering therapy. This randomized, double-blind, placebo-controlled Phase II study is conducted in 8 major medical centers in Taiwan.

18 Jun 2013

Vanda presents additional data from tasimelteon Phase III studies at ENDO 2013

Vanda Pharmaceuticals Inc. presented additional data today at ENDO 2013, the Endocrine Society's 95th Annual Meeting, demonstrating that tasimelteon can entrain (synchronize) both melatonin and cortisol rhythms.

18 Jun 2013

Therapy News and Research

AACE applauds the American Medical Association for recognizing obesity as disease state

Thrombolytic treatment after stroke associated with reduced in-hospital mortality

Psychologists must be educated to treat sexual minority youth

Ico Therapeutics completes Phase 2 iDEAL study for treatment of diabetic macular edema

Journal of Bone and Joint Surgery reveals important trends and changes in orthopaedic practice

State highlights: Texas pharmacists want Medicaid price transparency

Report examines Medicare spending issues, geographic disparities and hospital payments

Scientists discover new anti-tuberculosis compound that kills drug-resistant TB bacteria

Hormone treatment to halt puberty in transgender adolescents is safe and effective

OncoSec Medical completes enrollment in ImmunoPulse trial for metastatic melanoma patients

DTE from animal thyroid glands is a safe alternative to T4 therapy in hypothyroid patients

Combination of obesity and low testosterone increases risk of diabetes and brain damage

Genomic instability in new molecular pathway may predict worse outcomes in breast cancer patients

Estrogen replacement therapy reduces anxiety symptoms in girls with anorexia nervosa

Study: Whole body vibration therapy raises bone strength among adolescents with cerebral palsy

Women with polycystic ovary syndrome lose more weight when they take two drugs

State highlights: States urge using life insurance for long-term care

Vercise DBS System shows improvement in motor scores for patients with Parkinson's disease

TWi Biotechnology completes patient enrollment in phase II trial of AC-201 for Gout Flare Prophylaxis

Vanda presents additional data from tasimelteon Phase III studies at ENDO 2013

Industry Focus eBook - Cell biology (5th edition) eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News